AMI Software and Elsevier Announce Agreement for Integration of Scopus Data into AMI Enterprise Intelligence
AMI Software (AMI), a leading provider of market intelligence solutions, and Elsevier, world-leading provider of scientific, technical and medical information products and services, announce the agreement to provide AMI Software’s core product AMI Enterprise Intelligence (AMI EI) with access to data from Scopus, the largest abstract and citation database of peer-reviewed literature, with smart tools that track, analyze and visualize research.
The AMI-Elsevier agreement allows AMI customers, with a subscription to Scopus, to import bibliographic records from Scopus, via an automated process, into AMI EI. This allows them to significantly improve the quality and the relevance of their online monitoring and data collecting projects, expanding on their capabilities of online information analyses and distribution.
“The creation of a dedicated Scopus connector by AMI Software will help us gain precious time in collecting scientific data. Combined with other information sources, this solution allows us to enrich our bibliographic collections from which we can derive our data and scientific literature analyses,” explains Odile Solich, responsible for monitoring activities at the Institut Pasteur de Lille.
Scopus contains more than 56 million records and 21,900 titles from 5,000 international publishers covering scholarly content in all disciplines: science, technology, medical, social sciences and arts and humanities. This added data will significantly strengthen AMI Software and will be directly available, by API, as new data source within the AMI EI platform.
“We are delighted to have signed this agreement with Elsevier,” said Alain Beauvieux, CEO of AMI Software. “The agreement demonstrates Elsevier’s confidence in AMI and represents a significant evolution in the breadth and value of Knowledge Management and Market Intelligence solutions AMI is able if offer its clients.”
“With the wide range of scholarly content that Scopus covers, as well as its additional functionality, we are able to provide valuable insights into research production and impact, said Cameron Ross, Vice President of Product Management, Abstract & Indexing Databases at Elsevier, “We hope to meet the needs of AMI customers so that they can more accurately assess research information available online.”
About AMI Software
AMI Software (AMI) designs and develops competitive and market intelligence software to capitalize on the value of online information. Our software enables internet monitoring, internet intelligence development, evidence-based horizon scanning and identification of early warning signals and assessment of security, threat and risk. Deployed in multiple countries, languages and industries our innovative products are used in the most demanding of information processing environments.
AMI provides both the technology and operational expertise necessary to ensure absolute success in delivery of our clients’ business intelligence projects. With over 150 clients, AMI contributes to the success of many international organizations. The company has offices in the UK, France and Morocco with partner offices in the United Arab Emirates and Tunisia.
Scopus is the largest abstract and citation database of peer-reviewed literature and features tools to track, analyze and visualize scholarly research. Its comprehensive database contains 55+ million items indexed from 21,000 titles from more than 5,000 publishers worldwide, ensuring broad interdisciplinary coverage in the fields of science, technology, medicine, social sciences and arts and humanities. Scopus was designed and developed with input from researchers and librarians and features direct links to subscribed full-text articles, other library resources and interoperability with applications such as reference management software. Scopus is part of the Elsevier Research Intelligence portfolio which includes the SciVal tools, the Pure system, rich data assets and custom Analytical Services.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com